Attorney General Jason Miyares joined a bipartisan group of 25 other state attorneys general calling on the Centers for Medicare and Medicaid Services to provide coverage for a drug approved by the U.S. Food and Drug Administration proven to delay the progression of Alzheimer’s Disease. The attorneys general asked the centers to provide full and unrestricted Medicare coverage for Alzheimer’s treatments consistent with its practice of covering FDA-approved prescription drugs for Medicare beneficiaries.